COCP Cocrystal Pharma Inc

For the fiscal year ended 31/12/2022: Cocrystal Pharma Inc's revenues decreased by NaN and amounted to 0.00. Net income decreased by 173.79% to -38.84M. Net assets decreased by NaN to 39.57M and EPS decreased from N/A to -4.77.